Tabb Sullivan
About Tabb Sullivan
Tabb Sullivan is a Senior Research Scientist and Project Leader at Integral Molecular, where he has worked since 2015. He specializes in discovering targets for orphan phenotypic antibodies using MPA technology and has extensive experience in cancer immunotherapy and gene therapy applications.
Work at Integral Molecular
Tabb Sullivan has been employed at Integral Molecular as a Senior Research Scientist and Project Leader (MPA) since 2015. In this role, he focuses on discovering targets for orphan phenotypic antibodies using Membrane Proteome Array (MPA) technology. Sullivan develops new technology to enhance MPA for high-throughput screening applications. His work involves identifying off-target binding of antibodies to reduce risks in therapeutic development. He also uncovers functional receptors for viruses and protein ligands through MPA technology.
Education and Expertise
Tabb Sullivan holds a Bachelor's degree in Biology and Computer Science from Hampshire College, where he studied from 1993 to 1997. He earned his Doctor of Philosophy (PhD) in Microbiology and Immunology from the University of North Carolina at Chapel Hill, completing his studies from 2006 to 2012. Sullivan possesses expertise in cancer immunotherapy and CAR-T cell therapy, and he is skilled in vector design and characterization for gene therapy applications. He is also trained in lean methodologies and value stream mapping to enhance research processes.
Background
Before joining Integral Molecular, Tabb Sullivan worked at Thomas Jefferson University as a Postdoctoral Fellow from 2012 to 2015. He also served as a Research Assistant at the University of Virginia from 2004 to 2006. Prior to his academic career, he volunteered with the Peace Corps in Senegal from 2001 to 2003. His extensive background in research and development spans various institutions and roles, contributing to his current expertise in the field.
Achievements
Throughout his career, Tabb Sullivan has developed functional assays and managed standard operating procedures (SOPs) to streamline research efforts. His contributions to the field of immunotherapy and gene therapy are significant, particularly in the context of high-throughput screening and therapeutic development. Sullivan's work in uncovering functional receptors and mitigating risks in antibody development reflects his commitment to advancing scientific knowledge and application.